Register
.
RSSDI 2018 

Gujarat University Convention Centre, Ahmedabad,  22 November 2018 -25 November 2018


Conferences
Pathophysiological Rationale for Combination Therapy vs. Conventional Stepwise Treatment Approach
Dr Ambrish Mithal, Gurugram, 23 November 2018
#Diabetes and Endocrinology #Diabetes and Endocrinology
 The ominous octet”: Decreased incretin effect, increased lipolysis, increased glucose reabsorption, decreased glucose uptake, increased hepatic gluc ...MORE
505 Views
0 Comments

Conferences
SUs Revisited
Dr Rajesh Marya, New Delhi, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
Data suggest that treatment with SUs leads to 0.5-2% HbA1c reduction compared to other therapies. Current literature does not support the notion that SUs are ha ...MORE
530 Views
0 Comments

Conferences
Diabetes and Stroke
Dr Prakash Keswani, Jaipur, 24 November 2018
#Diabetes and Endocrinology #Neurology
Patients with diabetes are at a 2-4 times higher risk of stroke and greater sequelae.Factors contributing to stroke in these patients are HT, dyslipidemia and i ...MORE
515 Views
0 Comments

Conferences
Heavy Metals, Diabetes and Cardiovascular Risk
Dr Sanjiv Shah, Mumbai, 24 November 2018
#Cardiology #Diabetes and Endocrinology
Metals enter into the body via fumes and aerosols, which precipitate and contaminate the soil and surface water. The residues can be directly taken up or deposi ...MORE
549 Views
0 Comments

Conferences
Current Technologies in Diabetes Management
Dr Jothydev Kesavadev, Trivandrum, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
Diabetes is a complex disease where intelligent use of technologies is indispensable in a majority of patients to maintain the quality of life.Wearable devices, ...MORE
461 Views
0 Comments

Conferences
Future Treatments for Diabetes From Concept to Care
Dr Shashank Joshi, Mumbai, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
Omarigliptin: It is not an extended release formulation; the mechanism of action is same as q.d siblings. The difference is in the duration of meaningful DPP-4& ...MORE
536 Views
0 Comments

Conferences
Treat the Person and not Just the Disease
Prof Dr KK Aggarwal, 24 November 2018
#Diabetes and Endocrinology #Public Health
Our health is not just determined by eating healthy or regular check-ups or even taking the right vaccinations at the right time. The conditions which we live i ...MORE
451 Views
0 Comments

Conferences
Diabesity: The Recent Concern
Dr Anil Kumar Virmani, Jamshedpur, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
Diabesity is a growing worldwide epidemic with an enormous impact on morbidity and mortality.Presence of obesity in a diabetic patient can hinder both diabetes ...MORE
566 Views
0 Comments

Conferences
Inflammation, Immunity and Metabolism
Dr Narsingh Verma, Lucknow, 24 November 2018
#Cardiology #Diabetes and Endocrinology
Inflammation has a role in several chronic diseases such as diabetes, cancer, cardiovascular, Alzheimer’s disease, arthritis, neurological diseases.Adipos ...MORE
539 Views
0 Comments

Conferences
GLP-1 Analogue: Extra Glycemic Benefits
Dr SK Sharma, Jaipur, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
GLP-1 agonists are preferred in management of T2DM, weight reduction; they are free of hypoglycemia (used as second-line therapy as add-on + an insulin sensitiz ...MORE
610 Views
2 Comments

Conferences
Pathophysiology of Macrovascular Impact of Psoriasis in Diabetes
Dr Aastha Chawla, Bikaner, 24 November 2018
#Dermatology #Diabetes and Endocrinology
 Prevalence of diabetes has been shown to be high in psoriasis patients.Studies have demonstrated a higher prevalence of diabetes in patients who have psor ...MORE
545 Views
0 Comments

Conferences
Alarming Signs of Diabetic Kidney Disease - Time for a Nephrologist?
Dr Arvind Gupta, Jaipur, 24 November 2018
#Cardiology #Diabetes and Endocrinology
Physicians should be able to recognize alarming signs early in the course of the disease, and give appropriate treatment, or do timely referral to the Nephrolog ...MORE
601 Views
1 Comments

Conferences
Managing Diabetes in Low Resource Settings
Dr Mayur Patel, Ahmedabad, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
WHO recommendations:Point of care devices can be used in diagnosing diabetes if laboratory services are not available.Advise overweight patients to reduce weigh ...MORE
569 Views
2 Comments

Conferences
What Next After Metformin? A Million Dollar Question
Dr CL Nawal, Jaipur, 24 November 2018
#Cardiology #Diabetes and Endocrinology
Options available after metformin – Oral drugs: SUs, meglitinides, DPP-4i, SGLT2i, TZDs, alpha-glucosidase inhibitors, bromocriptine; Injectables: GLP-1 a ...MORE
453 Views
0 Comments

Conferences
Novel Biomarkers in Diabetic Complications
Dr Sudha Vidyasagar, Manipal, 24 November 2018
#Cardiology #Diabetes and Endocrinology
Novel biomarkers may help in detecting diabetic complications much earlier than traditional ones. They may predict incidence and progression of these complicati ...MORE
564 Views
0 Comments

Conferences
Etiopathogenesis and Management of Diabetic Heart Failure
Dr Dheeraj Kapoor, 24 November 2018
#Cardiology #Diabetes and Endocrinology
Heart failure (HF) in patients with diabetes is still under-recognized and misdiagnosed. Untreated or undertreated HF has very poor prognosis.HF occurs at an ea ...MORE
536 Views
0 Comments

Conferences
Prevention of Diabetes: Is It Possible?
Dr GD Ramchandani, Kota, 24 November 2018
#Diabetes and Endocrinology #Gastroenterology
The Indian Diabetes Prevention Program (IDPP): Both lifestyle modification and metformin significantly reduced the incidence of diabetes in Asian Indians with i ...MORE
552 Views
1 Comments

Conferences
Positioning SGLT2 Inhibitors in Diabetes Treatment Algorithm
Dr Ambrish Mithal, 24 November 2018
#Cardiology #Diabetes and Endocrinology
According to the AACE 2018 guidelines, SGLT2i are recommended over other AHAs.According to the ADA/EASD 2018 consensus statement, SGLT2i are the preferred OHAs ...MORE
545 Views
0 Comments

Conferences
DKA in Type 1 Diabetes
Dr Siddhant Trehan, Gurugram, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
Insulin deficiency with raised levels of counter-regulatory hormones leads to diabetic ketoacidosis (DKA).DKA occurs mostly in type 1 diabetes, whereas hyperosm ...MORE
477 Views
0 Comments

Conferences
Clinical Challenges of Diabetes in Older People: Goals of Care
Dr Sanjiv Shah, Mumbai, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
The prevalence of diabetes is rising in the >65 year-old age group.Diabetes in older people poses several challenges. The challenges include heterogeneity, h ...MORE
518 Views
0 Comments

Conferences
FDCs in T2DM Management - How Effective?
Dr Mangesh Tiwaskar, Mumbai, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
In spite of the current OAD armamentarium, diabetes control is far from satisfactory. Initial combination treatment, specifically as FDC, has several distinct a ...MORE
471 Views
0 Comments

Conferences
Mobile Apps can Change Outcomes
Dr Jaiprakash Sai, Hyderabad, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
Mobile App Rating Scale (MARS), a reliable and validated scoring instrument of mHealth app quality, was used in a study to assess the quality of the most popula ...MORE
468 Views
0 Comments

Conferences
Biomarkers in Type 1 Diabetes Mellitus
Dr Meena Chhabra, New Delhi, 24 November 2018
#Diabetes and Endocrinology #Internal Medicine
Biomarkers in the form of antibodies certainly help to establish if an individual is at an increased risk to develop T1DM, but their positivity does not correla ...MORE
458 Views
0 Comments

Conferences
The Diet Dilemma: A Diabetes Dialogue
Dr PV Rao, Hyderabad, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
A healthy Indian diet pattern is recommended due to its protective role in high risk individuals with T2DM (2017 RSSDI clinical practice recommendations for T2D ...MORE
458 Views
0 Comments

Conferences
Female Gender is Key to Noncommunicable Disease Prevention
Prof V Seshiah, Chennai, 26 November 2018
#Diabetes and Endocrinology #Obstetrics and Gynecology
IDF Atlas 2017 documented that the total number of persons with diabetes increased from 151 million in 2002 to 425 million in 2017. Is there a hope to reverse t ...MORE
486 Views
0 Comments

Conferences
Evolving Landscape of DPP-4 CVOTs: CARMELINA in Focus
Dr Merlin Thomas, Australia, 26 November 2018
#Cardiology #Diabetes and Endocrinology
DPP-4 inhibitors are a good treatment option in type 2 diabetes as they are easy to use, no titration is required, have sustained efficacy across a broad range ...MORE
458 Views
0 Comments

Conferences
Paradigm Shift in Diabetes
Dr Sundeep Ruder, South Africa, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
Scientific and technological advances continue to expand in the field of diabetes. Yet, the percentage of patients achieving a target HbA1c is unchanged and dia ...MORE
443 Views
0 Comments

Conferences
Screening for DR: Is India Ready?
Dr SR Aravind, Bengaluru, 26 November 2018
#Diabetes and Endocrinology #Ophthalmology
An interobserver reliability study of 12 ophthalmic care personnel (3 retina specialists, 3 general ophthalmologists, 3 ophthalmic nurses and 3 ophthalmic ...MORE
488 Views
0 Comments

Conferences
Disease Prevention should also Focus on Plant, Animal and Environmental Health
Prof Dr KK Aggarwal, 26 November 2018
#Diabetes and Endocrinology #Infectious Diseases
The concept of “One health” has been gradually gaining ground in the last few years. When we talk of One Health, it includes plants, animals, enviro ...MORE
464 Views
0 Comments

Conferences
Use of Fibrates in Metabolic Syndrome and Diabetes: Practical Tips
Prof. Sudarshan Ramachandran, UK, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
The evidence for fibrates mainly exists in patients with elevated triglycerides and low HDL-C levels.Mechanisms leading to change in TGs and HDL-C levels may be ...MORE
462 Views
0 Comments

Conferences
Charcot Foot: Overview and Latest Developments
Dr Jamal Ahmad, Aligarh, 26 November 2018
#Diabetes and Endocrinology #Infectious Diseases
Charcot foot is a systemic disease that generates pathological changes in the musculoskeletal system, causing fractures, dislocations and deformities in the foo ...MORE
504 Views
0 Comments

Conferences
Combination of Empagliflozin and linagliptin: A Leap Towards Holistic Type 2 Diabetes Management
Dr Binayak Sinha, 26 November 2018
#Cardiology #Diabetes and Endocrinology
The combination addresses multiple pathophysiological defects. The high efficacy provides significant reduction in A1c across baselines. It offers significant w ...MORE
533 Views
0 Comments

Conferences
Nondiabetic Ocular Complications in Diabetic Patients
Dr Chandrasekhar Valupadas, Telangana, 26 November 2018
#Diabetes and Endocrinology #Ophthalmology
Diabetic retinopathy (DR) is the most frequent cause of blindness.Cataract is common all over the world and affects people with diabetes. At first, glaucom ...MORE
552 Views
0 Comments

Conferences
Manipulating Macronutrients for Weight Reduction - Important or Just Calorie Reduction!
Dt. Kavita Gupta, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
There are reports showing that appetite, control of body weight and energy compensation are influenced by the macronutrient composition of meals (amount of fat, ...MORE
473 Views
0 Comments

Conferences
Updates in DR Management
Dr Deependra Vikram Singh, Gurugram, 26 November 2018
#Diabetes and Endocrinology #Ophthalmology
Updates in DR Management in Last DecadeFollowing are the key advancements in the management of DR in the last decade:Acceptance of digitalized fundus images as ...MORE
487 Views
0 Comments

Conferences
Role of Bile Acid Sequestration in Glucose Homeostasis
Dr Prabha Adhikari, Mangalore, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
Bile acids have a role in lipid, glucose homeostasis and energy expenditure. They regulate glucose through their effect on maintenance of normal gut microbiota ...MORE
550 Views
0 Comments

Conferences
CVOTs with DPP-4 Inhibitors
Dr Rajesh Rajput, Rohtak, 26 November 2018
#Cardiology #Diabetes and Endocrinology
CV safety outcome data is available with 3 out of 6 gliptins in India.Hospitalization for heart failure cannot be considered a class effect.Gliptins have establ ...MORE
458 Views
0 Comments

Conferences
Lipodystrophies: Clinical Phenotypes and Underlying Mechanisms
Dr Justin Rochford, UK, 26 November 2018
#Cardiology #Diabetes and Endocrinology
Lipodystrophies are a range of metabolic conditions that may be acquired or inherited, which feature altered mass or distribution of adipose tissue.The genetic ...MORE
489 Views
0 Comments

Conferences
Nondiabetic Kidney Disease - When to Suspect?
Dr Anuj Maheshwari, Lucknow, 26 November 2018
#Diabetes and Endocrinology #Nephrology
Renal insufficiency without significant proteinuria.Proteinuria in the absence of diabetic retinopathy.Hematuria with RBC casts.Rapid decline of GFR.Rapid devel ...MORE
547 Views
0 Comments

Conferences
Diabetes Management in Chronic Liver Disease
Dr Soumitra Ghosh, Kolkata, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
Liver is the most vital organ for metabolic homeostasis.It is important to categorize the patients.Set realistic and safe goals.Recognize limitations and variab ...MORE
474 Views
0 Comments

Conferences
Ectopic Fat and Risk of Diabetes
Dr Shehla Shaikh, Mumbai, 26 November 2018
#Diabetes and Endocrinology #Gastroenterology
Ectopic fat may be defined as the accumulation of TG in non-adipose lean tissues having no capacity for fat storage, resulting in organelle, cellular and organ ...MORE
493 Views
0 Comments

Conferences
SGLT2 Inhibitors and Kidneys
Dr Manisha Sahay, Hyderabad, 26 November 2018
#Diabetes and Endocrinology #Nephrology
Diabetes is the most important contributor to the growing burden of ESRD. About 30-40% of all kidney diseases in India are due to diabetes.SGLT2i reduce renal g ...MORE
478 Views
0 Comments

Conferences
Safe and Smart Use of Modern Sulfonylureas: The Compelling Benefits
Dr SR Aravind, Bengaluru, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
Sulfonylureas (SUs) are important components in the treatment of T2DM.Treatment with SUs results in maximum reduction of HbA1c.Modern SUs like glimepiride have ...MORE
467 Views
0 Comments

Conferences
Asian Indian Phenotype
Dr Mala Dharmalingam, Bengaluru, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
The “Asian Indian Phenotype” refers to certain unique clinical and biochemical abnormalities in Indians which include: Increased insulin resistance; ...MORE
443 Views
0 Comments

Conferences
Peculiar Infections in Diabetes
Prof Jayanta Kumar Panda, Cuttack, 26 November 2018
#Diabetes and Endocrinology #Infectious Diseases
Diabetes mellitus (DM) is a secondary immunodeficiency state.It predisposes an individual to various infections. Infections are more prevalent, severe and are a ...MORE
503 Views
0 Comments

Conferences
Nutrition and Self Care Tips for Diabetics
Dr Dinesh Agarwal, Guwahati, 26 November 2018
#Diabetes and Endocrinology
Part I: Foods to Encourage or Discourage:Eat more fruits, vegetables and nuts in place of processed carbohydrates.Choose healthier proteins, like lean meat, chi ...MORE
463 Views
0 Comments

Conferences
Metformin Revisited
Prof Hemraj Chandalia, Mumbai, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
Metformin is in extensive use since 1950s in India and other countries. It was introduced in the USA in 1995. The treatment algorithm of type 2 diabet ...MORE
484 Views
0 Comments

Conferences
Diabetes and Tuberculosis: Dual Epidemic
Dr Vijay Viswanathan, Chennai, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
With a startling augment in the co-existence of tuberculosis (TB) and diabetes mellitus (DM), India has to combat an immense burden of eradicating two potential ...MORE
462 Views
0 Comments

Conferences
PCSK9 Inhibitors in Diabetic Dyslipidemia
Prof Sudarshan Ramachandran, UK, 26 November 2018
#Cardiology #Diabetes and Endocrinology
Despite recent debate, the evidence for the lipid hypothesis still remains strong.PCSK9 inhibitors are third-line LDL-C lowering agents in the UK. The efficacy ...MORE
480 Views
0 Comments

Conferences
AGP - A Novel Tool to Personalize Diabetes Management for Each Patient
Dr Jothydev Kesavadev, Trivandrum, 26 November 2018
#Diabetes and Endocrinology #Internal Medicine
Ambulatory glucose profile (AGP) has been a game changer in diabetes.In type 2 diabetes, AGP provides data on glucose trends, hypoglycemia, hyperglycemia, perce ...MORE
440 Views
0 Comments

Conferences
Dysglycemic Detection Drive in Bangalore (East) Under the Aegis of KRSSDI-2017
Dr Raja Selvarajan, 27 November 2018
#Diabetes and Endocrinology #Internal Medicine
India leads the world and stands at the second position after China, with 69 million persons affected by diabetes.KRSSDI 2017, as a social responsibility initia ...MORE
490 Views
0 Comments

Conferences
INDIAB Data - Population-specific Characteristics of Diabetes in India
Dr RM Anjana, Chennai, 27 November 2018
#Diabetes and Endocrinology #Internal Medicine
Prevalence of diabetes in India varies widely in different states from 4.3% in Bihar to 13.6% in Chandigarh.The results show evidence of an epidemiological tran ...MORE
442 Views
0 Comments

Conferences
Diabetes and Sarcopenia
Dr Amit A Saraf, Mumbai, 27 November 2018
#Diabetes and Endocrinology #Internal Medicine
Sarcopenia, a pre­viously under-appre­ciated risk factor for type 2 diabetes in older adults, must be monitored and lifestyle modification for primary a ...MORE
457 Views
0 Comments

Conferences
Telephonic Consultations: How Safe are They?
Prof Dr KK Aggarwal, 27 November 2018
#Diabetes and Endocrinology
In a recent judgment, the Bombay High Court turned down the anticipatory bail pleas of a doctor couple booked for the death of a woman patient under Section 304 ...MORE
466 Views
0 Comments

Conferences
GDM Manifests in All Trimesters
Dr V Balaji, Chennai, 27 November 2018
#Diabetes and Endocrinology #Obstetrics and Gynecology
Ethnically, Indian women are more prone to develop GDM. Universal screening is necessary in the Indian context.Customized Screening – Community: 75 g gluc ...MORE
444 Views
0 Comments

Conferences
Data from New Delhi - Characteristics of Patients with DM Attending a Tertiary Care Center in East Delhi
Dr Sandeep Goyal, New Delhi, 27 November 2018
#Diabetes and Endocrinology #Diabetes and Endocrinology
   As expected, most of the patients are of type 2 diabetes; the proportion of female patients is higher as compared to males.Age at presentation is c ...MORE
446 Views
0 Comments

Conferences
Initiating on Pump Therapy
Dr Vinay Mukhekar, Mumbai, 27 November 2018
#Diabetes and Endocrinology #Internal Medicine
Insulin pump therapy is the most physiological method of insulin delivery.Initiating insulin therapy is simple and easy.Patients can be trained to use insulin p ...MORE
458 Views
0 Comments

Conferences
Emerging Science of EXERKINES Towards Diabetes Prevention & Management
Dr M Balasubramanyam, Chennai, 27 November 2018
#Diabetes and Endocrinology #Diabetes and Endocrinology
     Exercise and lifestyle modification is the key for preventing and managing noncommunicable diseases, including type 2 diabetes.Then what pre ...MORE
471 Views
0 Comments

Conferences
Glycemic Status Evaluation in Newly Diagnosed Type 2 Diabetes Adult Indian Patients and Requirement of Insulin Therapy at the Time of Diagnosis
Dr Tarang Shah, 27 November 2018
#Diabetes and Endocrinology #Diabetes and Endocrinology
Indians have very poor glycemic status at the time of their diagnosis. This can be labeled as awareness inertia.India needs a screening program for type 2 diabe ...MORE
479 Views
0 Comments

Conferences
Insulin Resistance in Type 2 Diabetes Mellitus
Dr Pratap P Jethwani, Rajkot, 27 November 2018
#Diabetes and Endocrinology #Internal Medicine
Insulin resistance (IR) is the impairment in insulin action at target cells such as liver cells, adipocytes and muscle cells. In 1939, Harold Himsworth, while a ...MORE
503 Views
0 Comments

Conferences
Identification of High Risk Foot, History Taking and Clinical Examination
Dr Ashish S Dengra, Jabalpur, 27 November 2018
#Diabetes and Endocrinology #Infectious Diseases
High risk foot is defined as a foot with progressive deformity, ulceration, infection and/or amputation as a result of diabetes or any other medical condition.L ...MORE
451 Views
0 Comments

Conferences
Updates on the Outcome Trials of Canagliflozin
Dr AK Singh, Kolkata, 27 November 2018
#Cardiology #Diabetes and Endocrinology
The beneficial pleiotropic effects of canagliflozin within the CV system and renal system, together with its favorable safety profile, make it an attractive med ...MORE
441 Views
0 Comments

Conferences
Key Findings from INITIAL Study - A Real World Evidence
Dr Manoj S Chawla, Mumbai, 27 November 2018
#Diabetes and Endocrinology #Internal Medicine
Challenges to good glycemic control – The ‘deadly’ triad: Progressive disease; clinical inertia; poor adherence to management regimens. Intens ...MORE
479 Views
0 Comments

Conferences
Glucagon - The Missing Link
Dr Sanjay Kalra, Karnal, 27 November 2018
#Diabetes and Endocrinology #Internal Medicine
Excess glucagon in T1DM leads to glycogenolysis and DKA.Metabolic fulcrum and metabolic triage: Predominant catabolism – Phenotype: thin built, cachexia, ...MORE
448 Views
0 Comments

Conferences
VADT at 15 years
Dr G Vijaya Kumar, Chennai, 27 November 2018
#Cardiology #Diabetes and Endocrinology
The Veterans Affairs Diabetes Trial (VADT) randomly assigned 1791 military veterans who had a suboptimal response to T2DM therapy to receive either intensive or ...MORE
461 Views
0 Comments

Conferences
BMI Changes in Uncontrolled T2DM: A Report from Diabetes Specialty Clinic
Dr Sanjoy Paul, Hyderabad, 27 November 2018
#Diabetes and Endocrinology
Obesity is a chronic disease characterized by accumulation of fat, where the body weight exceeds by 20%. Overall, a mean BMI change of -0.5 kg/m2 was observed i ...MORE
497 Views
0 Comments

Conferences
Time to overcome multifactorial therapeutic inertia
Dr Banshi Saboo, Ahmedabad, 27 November 2018
#Diabetes and Endocrinology #Diabetes and Endocrinology
True clinical inertia exists only if:recommendation exists;provider knows the recommendation;provider believes the recommendation applies to the patient;provide ...MORE
500 Views
0 Comments

Conferences
CVOTs with GLP-1 Receptor Agonists: How Significant?
Dr Ajay Kumar, Patna, 27 November 2018
#Cardiology #Diabetes and Endocrinology
GLP-1 may affect cardiac function indirectly through its actions on pancreatic islets to increase insulin secretion and inhibit glucagon secretion. Evidence poi ...MORE
552 Views
0 Comments

Conferences
Obstructive Sleep Apnea and Diabetes - The Link
Dr Anil Bhoraskar, Mumbai, 27 November 2018
#Diabetes and Endocrinology #Neurology
Diabetes and obstructive sleep apnea (OSA) present similar symptoms including obesity, impaired glucose metabolism, nocturnal sweating and nocturia, erectile dy ...MORE
518 Views
1 Comments

Conferences
Clinical Utilization of RSSDI Guideline
Dr Vidyut Shah, Rajkot, 27 November 2018
#Diabetes and Endocrinology
RSSDI Wheel guideline is the first of its kind guideline which is comprehensive and covers almost all clinical situations which we face in our day-to-day practi ...MORE
511 Views
0 Comments

Conferences
Focusing on T2DM Management in Special Population: Highlighting the Requisites
Dr Samar Banerjee, 27 November 2018
#Cardiology #Diabetes and Endocrinology
CV complications are common in elderly T2DM patients. Elderly patients are more prone to hypoglycemia, infections, volume depletion, fractures, etc. Vildaglipti ...MORE
474 Views
0 Comments

Conferences
Management of T2DM with Heart Failure: A New Paradigm
Dr Rajesh Rajput, 27 November 2018
#Cardiology #Diabetes and Endocrinology
One out of four DM patients has undiagnosed heart failure (HF). Both HF and diabetes are global epidemics with tremendous costs on the society. Although each be ...MORE
497 Views
0 Comments

Conferences
Critical Analysis of CVOTs of DPP-4 Inhibitors
Dr AK Singh, Kolkata, 27 November 2018
#Cardiology #Diabetes and Endocrinology
Gliptins have been shown to be safe (by 3P/4P MACE) in patients with history of CVD or at risk of CVD. HHF cannot be considered a class effect. Positive impact ...MORE
490 Views
0 Comments

Conferences
Metformin Journey of 6 Decades: Weed to a Wonder Drug
Dr YP Munjal, 27 November 2018
#Cardiology #Diabetes and Endocrinology
Metformin is the first-line drug for the treatment of T2DM. Metformin could be recommended as first-line treatment for patients with T2DM and HF who have preser ...MORE
499 Views
0 Comments

Conferences
T2DM Management - Newer Concepts
Dr RR Singh, Jhansi, 27 November 2018
#Diabetes and Endocrinology #Internal Medicine
Incidence of diabetes is increasing day by day in the Indian population. Regular exercise, good sleep for 6-7 hr, weight in limits, diet control, healthy foods ...MORE
471 Views
0 Comments

Conferences
Insulin Pump - Evidence from Current Era
Dr Om J Lakhani, Ahmedabad, 27 November 2018
#Diabetes and Endocrinology #Pediatrics
Insulin pumps improve glycemic control in adults with type 1 diabetes. They may have benefit in children as well for glycemic control. Insulin pumps reduce the ...MORE
484 Views
1 Comments
Previous Years Coverage